140 results on '"Muley, Suraj"'
Search Results
2. Ravulizumab Use for Acetylcholine Receptor-positive Generalized Myasthenia Gravis in Clinical Practice (P4-11.007)
3. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
4. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
5. Immunohistochemistry and electrophysiological findings in swine abattoir workers with immune-mediated polyradiculoneuropathy
6. Early deterioration of CIDP following transition from IVIG to FcRn inhibitor treatment
7. Safety and outcomes with efgartigimod use for acetylcholine receptor‐positive generalized myasthenia gravis in clinical practice.
8. Impact of the updated chronic inflammatory demyelinating polyneuropathy guideline on everyday clinical practice
9. Response of Sjogren-related Small Fiber Neuropathy to rituximab
10. Congenital Myasthenic Syndromes
11. Multifocal motor neuropathy
12. Treatment Burden According to Patients with Generalized Myasthenia Gravis (P6-13.008)
13. A Rare Case of Burkitt’s Lymphoma Presenting With Features Mimicking Vogt-Koyanagi-Harada Disease
14. Inflammatory demyelinating neuropathies
15. The use of eculizumab in ventilator‐dependent myasthenia gravis patients
16. Carpal tunnel syndrome with equivocal electrophysiological findings: Additional testing may improve diagnostic sensitivity
17. Chapter 35 Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy
18. A Rare Case of Burkitt’s Lymphoma Presenting with Features Mimicking Vogt Koyanagi Harada Disease (921)
19. Refractory Myasthenia Responsiveness to Eculizumab in a Tertiary Care Setting in Challenging Cases (77)
20. Rituximab in refractory chronic inflammatory demyelinating polyneuropathy
21. Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With Pulsed Oral Steroids
22. Response to Oral Supplementation in Copper Deficiency Myeloneuropathy
23. Isolated Bibrachial Plexopathy in a Patient With Type 2 Diabetes
24. Isolated Gait Ataxia Due to Cerebellar Vermis Infarct
25. The Evaluation of Preprocessing Choices in Single-Subject BOLD fMRI Using NPAIRS Performance Metrics
26. Phenotypic Variability Leads to Under-recognition of HNPP
27. Elevation of 14-3-3 and Unique MRI findings in a Case of Logopenic Variant Primary Progressive Aphasia (P2.1-034)
28. A Rare Case of Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) with Hyperreflexia in North America (P1.9-057)
29. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
30. The Quantitative Evaluation of Functional Neuroimaging Experiments: The NPAIRS Data Analysis Framework
31. Effects of Changes in Experimental Design on PET Studies of Isometric Force
32. Intravenous versus subcutaneous immunoglobulin – Authors' reply
33. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
34. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis
35. Management strategies in chronic inflammatory demyelinating polyradiculoneuropathy
36. Diabetic and non-diabetic lumbosacral radiculoplexus neuropathy
37. Pallet Sorting using Optical Character Recognition
38. Overlap of idiopathic and IgG4-related hypertrophic pachymeningitis: Case Series (P2.385)
39. Book Review
40. Intravenous versus subcutaneous immunoglobulin – Authors' reply
41. Post-streptococcal vasculopathy with evolution to Degos' disease
42. Congenital Myasthenic Syndromes
43. The Evaluation of Preprocessing Choices in Single-Subject BOLD fMRI Using NPAIRS Performance Metrics
44. Recurrent orthostatic numbness with carotid stenosis and beta-blocker use
45. Evaluating preprocessing choices in single-subject BOLD-fMRI studies using data-driven performance metrics
46. The quantitative evaluation of functional neuroimaging experiments: The NPAIRS data analysis framework
47. Learning curves for evaluation of neuroimaging experiments
48. Paraneoplastic vasculitic neuropathy related to carcinoid tumor.
49. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
50. Devon I. Rubin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.